STOCK TITAN

Boston Scientific Corp. - BSX STOCK NEWS

Welcome to our dedicated news page for Boston Scientific (Ticker: BSX), a resource for investors and traders seeking the latest updates and insights on Boston Scientific.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Boston Scientific's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Boston Scientific's position in the market.

Rhea-AI Summary
Boston Scientific is working to ensure that all employees have the resources they need to feel they belong and can succeed at the company. The Hispanic Organization for Leadership & Achievement (HOLA) offers mentoring and speech coaching programs.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.72%
Tags
none
-
Rhea-AI Summary
Boston Scientific Corporation will webcast its conference call discussing financial results and business highlights for Q3 2023 on October 26, 2023, at 8:00 a.m. EDT.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.02%
Tags
-
Rhea-AI Summary
Boston Scientific (BSC) Inspires Over 70,000 Young People to Pursue STEM Careers in 2022
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.38%
Tags
none
Rhea-AI Summary
Boston Scientific Foundation supports non-profits with grants in STEM education and health programs. Employee volunteers determine grant recipients. Boston Scientific Foundation Europe focuses on digital health initiatives. In 2022, the Foundation gave 34 STEM grants, 21 health grants, and 118 college scholarships. Positive impact on communities and personal reward for employees.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.24%
Tags
none
-
Rhea-AI Summary
CVS Health appoints Michael F. Mahoney, Chairman and CEO of Boston Scientific, to its Board of Directors.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.24%
Tags
management
-
Rhea-AI Summary
Boston Scientific to acquire Relievant Medsystems for $850 million, expanding its neuromodulation portfolio and treatment options for chronic low back pain. Intracept system expected to generate sales over $70 million in 2023 and achieve over 50% YoY growth in 2024. Transaction expected to be immaterial to adjusted EPS in 2024 and slightly accretive in 2025. Amortization expense and acquisition-related charges may make the transaction more dilutive on a GAAP basis.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.06%
Tags
Rhea-AI Summary
Boston Scientific receives FDA approval for the latest-generation WATCHMAN FLX Pro Left Atrial Appendage Closure (LAAC) Device, designed to reduce stroke risk in patients with non-valvular atrial fibrillation (NVAF)
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.06%
Tags
-
Rhea-AI Summary
Boston Scientific Corporation (NYSE: BSX) will host an Investor Day meeting on September 20, 2023, to review its financial goals and long-term growth strategies. The company's first-half results in 2023 exceeded expectations, showcasing the strength of its category leadership strategy, commitment to clinical evidence generation, and global team. The meeting will be held in hybrid format, both in person in Boston and online as a webcast. Registration for the webcast is available on the company's investor website. Additionally, the company will webcast its conference call discussing Q3 financial results and business highlights on October 26, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.6%
Tags
-
Rhea-AI Summary
Boston Scientific announces positive results from the ADVENT clinical trial of the FARAPULSE PFA System for atrial fibrillation treatment
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.95%
Tags
Boston Scientific Corp.

NYSE:BSX

BSX Rankings

BSX Stock Data

100.13B
1.46B
0.19%
93.66%
0.85%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
US
Marlborough

About BSX

Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments.